News

Filter

Current filters:

AstraZeneca

1 to 9 of 2718 results

MedImmune and NIST partner on biological therapies

MedImmune and NIST partner on biological therapies

22-02-2015

MedImmune has signed a five-year agreement with the US Department of Commerce’s National Institute…

AstraZenecaBiotechnologyMedImmuneResearchUSA

Cloud computing offers big data solutions to big pharma

Cloud computing offers big data solutions to big pharma

20-02-2015

Pharmaceutical companies spend upwards of a decade and a billion dollars to bring new drugs and therapies…

AstraZenecaCode-NExostarPharmaceuticalResearch

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

AstraZeneca to pay $7.9 million to resolve kickback allegations in USA

12-02-2015

Anglo-Swedish pharma major AstraZeneca has agreed to pay the US government $7.9 million to settle allegations…

AstraZenecaCardio-vascularGastro-intestinalsLegalMarkets & MarketingNexiumPharmaceuticalPlendilPrilosecToprol XLUSA

US DEA de-schedules AstraZeneca’s Movantik

07-02-2015

The USA’s Drug Enforcement Administration (DEA) has de-scheduled UK pharma major AstraZeneca’s Movantik…

AstraZenecaGastro-intestinalsMovantiknaloxegolNektar TherapeuticsPharmaceuticalRegulationUSA

Profits and share price down as AstraZeneca announces fourth quarter and 2014 results

Profits and share price down as AstraZeneca announces fourth quarter and 2014 results

05-02-2015

Anglo-Swedish drug major AstraZeneca met its upgraded guidance for 2014, though both profits and share…

AstraZenecaCrestorFinancialNexiumPharmaceutical

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

AstraZeneca acquires rights to Actavis’ branded respiratory portfolio in USA and Canada

05-02-2015

Anglo-Swedish pharma major AstraZeneca has acquired the rights to Ireland-headquartered generics major…

ActavisAstraZenecaDalirespFinancialPharmaceuticalRespiratory and PulmonaryTudorza PressairUSA

1 to 9 of 2718 results

COMPANY SPOTLIGHT

Menarini

Back to top